This study is to investigate the global gene expression in parallel with regression of cardiac hypertrophy in response to treatment with temocapril or olmesartan in mice with transverse aortic constriction (TAC), and to confirm whether periostin is a target gene of olmesartan in mice with post-MI cardiac remodeling. This evidence concerns the gene POSTN and cardiac hypertrophy.